The Netherlands: SHS Capital acquires majority stake in Basic Pharma
Germany-based healthcare investor SHS Capital is acquiring a majority stake in Basic Pharma, a Dutch speciality pharmaceutical platform and full-service CDMO, providing a succession...
Asset-light pharma services enter new era: insight from the IIH Private Capital Conference
Asset-light pharma services are entering a new era as pharmaceutical companies grapple with increasingly complex regulatory, commercial and technological challenges. Although growth in pharma...
The Netherlands: Kimball Electronics acquires Helvoet Polymer Technologies
Nasdaq-listed Kimball Electronics, a US based contract manufacturing organisation (CMO), has acquired Helvoet Polymer Technologies, a Netherlands-based (CDMO) focused on microfluidics, diagnostics, and drug...
UK: Caidya announces strategic combination with Simbec-Orion
Global CRO, Caidya, has announced a strategic combination with UK-based CRO, Simbec-Orion, designed to close the divide between early scientific insight and global clinical execution.
The combination...
Italy: G Square acquires majority shareholding in Valtecne with view to delisting
G Square, an investment firm specialising in the healthcare sector, is acquiring approximately 82% of the share capital of Valtecne, an Italy-based listed contract...
UK: Eumar Technology acquires Hybrisan to advance wound care innovation and UK manufacturing
UK-based Eumar Technology, a specialist medical device manufacturer serving the global wound care market, has acquired Hybrisan, which specialises in advanced wound care innovation,...
Belgium: Marc Verbruggen appointed as managing director of Purna Pharma
Purna Pharmaceuticals, a specialty CDMO based in Belgium, has appointed Marc Verbruggen as managing director.
Verbruggen joins Purna from Normec Healthcare Belgium, where he was...
Norway: Rubicon Healthcare Partners appoints Claire Knoph as COO/CFO
Rubicon Healthcare Partners (RHP), a growth equity asset manager primarily focused on Nordic life science companies, has appointed Claire Knoph as COO and CFO.
Her...
Switzerland: CordenPharma expands global peptides platform in US and China
Switzerland-based global CDMO, CordenPharma, has agreed to acquire AmbioPharm, a US-headquartered peptide API CDMO, from Carlyle.
The acquisition builds on CordenPharma’s global facility network of 11...
Switzerland: Siegfried places CHF200m four-year senior bonds
SIX-listed CDMO, Siegfried, has issued a CHF200m four-year bond paying a coupon of 1.35%.
“This transaction further strengthens Siegfried’s financial position and maintains strategic flexibility...
Advertisement
